PEPTIDESMADE SIMPLE

Peptides for weight loss and metabolism

GLP-1 drugs and other compounds researched for appetite, body weight and metabolism. Semaglutide is an approved medicine, retatrutide and cagrilintide are in clinical trials, and the rest have mostly early research.

For education and research only. Not medical advice, and not a recommendation to use anything.

Side by side

What each one is and how much research is behind it.

NameWhat it isEvidence so far
5-Amino-1MQSmall molecule (NNMT inhibitor), not a peptideCell and mouse studies only; no published human trialsDosage
AOD-9604Synthetic peptide, 16 amino acids (modified growth hormone fragment)Positive animal data; human weight trials were disappointingDosage
CagrilintideInvestigational synthetic peptide (long-acting amylin analog)Phase 2 and 3 human trials, mostly combined with semaglutide
MOTS-cMitochondrial-derived peptide, 16 amino acidsMostly mouse studies; small observational human studiesDosage
RetatrutideInvestigational synthetic peptide (triple hormone receptor agonist)Phase 2 and phase 3 trial results; investigational as of 2026
SemaglutideModified GLP-1 peptide, 31 amino acidsMany large randomized human trials
SLU-PP-332Small molecule (ERR agonist), not a peptideCell and mouse studies only; no human trialsDosage
TesofensineInvestigational small molecule (monoamine reuptake inhibitor), not a peptidePhase 2 and some later human trials; investigationalDosage

Free for readers

The reader kit, plus an email when a new profile goes up.

A lab math worksheet, a lab log and a COA checklist that go with the books, and the free calculator.

Free. We'll send material on the peptides you've viewed here. Unsubscribe anytime. Privacy policy.

Free printable chartEvery common vial size, plus a lab log
Get it free